Company / Working Capital
PALVELLA THERAPEUTICS, INC. Working Capital History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$76.2M
FY2024
5-year range
$5.2M / $77.1M
FY2020-FY2024
Trend
+1368.7%
vs FY2023
Sector context
#202 of 213
Health Care
What the data says
Working Capital changed +1369% YoY in FY2024, a notable deviation from the 9-year average annual change of +156%.
Based on SEC 10-K filings.
$76M in FY2024 with a 5-year CAGR of -2.8%.
Improved from $37M to $76M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -0.4%
- 5-Year CAGR
- -2.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 213This company $76.2M Sector average $934.6M
▼
-91.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -2.8%, indicating a declining trend.
- In FY2024, working capital increased 1368.7% year-over-year.
- Ranks #202 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- Strong profit margin: 43.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $76.2M | +1368.7% |
| FY2023 | $5.2M | -85.9% |
| FY2022 | $36.8M | -52.2% |
| FY2021 | $77.1M | +43.8% |
| FY2020 | $53.6M | -39.1% |
| FY2019 | $88.0M | +0.8% |
| FY2018 | $87.3M | +98.4% |
| FY2017 | $44.0M | +81.2% |
| FY2016 | $24.3M | -15.8% |
| FY2015 | $28.9M | +77.2% |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 30, 2026